UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$388M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$359M |
| 3 |
ExxonMobil
XOM
|
+$284M |
| 4 |
TSMC
TSM
|
+$259M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$911M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$825M |
| 3 |
UBS Group
UBS
|
+$683M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$381M |
| 5 |
Willis Towers Watson
WTW
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.08% |
| 2 | Financials | 7.19% |
| 3 | Healthcare | 6.35% |
| 4 | Consumer Discretionary | 5.55% |
| 5 | Industrials | 4.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JFU
8276
9F Inc
JFU
$28.8M
| $11K | ﹤0.01% |
615
+416
| +209% | +$8.48K |
|
8277
Koss Corp
KOSS
$35.3M
| $11K | ﹤0.01% |
1,158
-1,395
| -55% | -$11.9K |
|
8278
LegalZoom.com
LZ
$1.42B
| $11K | ﹤0.01% |
750
+60
| +9% | +$902 |
|
8279
Mama's Creations
MAMA
$891M
| $11K | ﹤0.01% |
+6,843
| New | +$12.2K |
|
8280
Marchex
MCHX
$84.2M
| $11K | ﹤0.01% |
4,991
-742
| -13% | -$1.67K |
|
8281
Ballast Small/Mid Cap ETF
MGMT
$178M
| $11K | ﹤0.01% |
+310
| New | +$11.1K |
|
|
MYPSW
8282
DELISTED
PLAYSTUDIOS Inc Warrant
MYPSW
| $11K | ﹤0.01% |
+12,619
| New | +$9.03K |
|
8283
ProShares Short MidCap400
MYY
$2.92M
| $11K | ﹤0.01% |
473
-1,032
| -69% | -$24.7K |
|
8284
ENDRA Life Sciences
NDRA
$5.47M
| $11K | ﹤0.01% |
1
| – | – |
|
8285
PUT
Nokia
NOK
$55.6B
| $11K | ﹤0.01% |
2,000
-479,500
| -100% | -$2.66M |
|
8286
NRX Pharmaceuticals
NRXP
$128M
| $11K | ﹤0.01% |
453
-721
| -61% | -$23.5K |
|
8287
Nutriband Inc Warrant
NTRBW
$188K
| $11K | ﹤0.01% |
+1,210
| New | +$4.06K |
|
8288
Oragenics
OGEN
$2.44M
| $11K | ﹤0.01% |
17
+7
| +70% | +$5.13K |
|
8289
OneMedNet
ONMD
$45.6M
| $11K | ﹤0.01% |
+1,095
| New | +$11.1K |
|
8290
Perma-Fix Environmental Services
PESI
$362M
| $11K | ﹤0.01% |
+2,063
| New | +$12.1K |
|
|
PHAR
8291
Pharming Group
PHAR
$736M
| $11K | ﹤0.01% |
1,262
-66
| -5% | -$585 |
|
8292
Pluri
PLUR
$16.9M
| $11K | ﹤0.01% |
710
-839
| -54% | -$12.1K |
|
|
PRPH
8293
DELISTED
ProPhase Labs
PRPH
| $11K | ﹤0.01% |
150
-37
| -20% | -$2.57K |
|
8294
TransCode Therapeutics
RNAZ
$4.88M
| – | – |
0
| – | – |
|
|
SGMA
8295
DELISTED
Sigmatron International
SGMA
| $11K | ﹤0.01% |
+1,581
| New | +$13.2K |
|
8296
Stabilis Solutions
SLNG
$88.5M
| $11K | ﹤0.01% |
2,126
-86
| -4% | -$377 |
|
8297
SP Funds Dow Jones Global Sukuk ETF
SPSK
$647M
| $11K | ﹤0.01% |
+560
| New | +$10.7K |
|
8298
Transact Technologies
TACT
$57.1M
| $11K | ﹤0.01% |
1,530
+471
| +44% | +$4.19K |
|
8299
Team
TISI
$79.1M
| $11K | ﹤0.01% |
518
-562
| -52% | -$5.84K |
|
8300
Direxion Daily 7-10 Year Treasury Bear 3X ETF
TYO
$12.3M
| $11K | ﹤0.01% |
1,094
-2,246
| -67% | -$21K |
|
Similar funds
UBS Group's Q1 2022 Portfolio in Review
As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group withdrew a net $29.5B in Q1 2022, closing 1,160 positions and reducing 5,175 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Shell worth $66.6M.
- UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
- UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
- UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
- UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
- UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
- UBS Group opened 1,182 new positions and closed 1,160 in Q1 2022.
- UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.
Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.